Screener
Nurix Therapeutics, Inc. NRIX Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$89.54M-106% | -$87.17M-54.7% | -$78.22M-33.6% | -$86.42M-76.5% | -$43.46M+2.4% | ||
| $2.26M+0.6% | $2.2M-6.6% | $2.12M-16.8% | $2.03M-15.3% | $2.24M-3.8% | ||
| $11.39M+9.7% | $9.4M+7.8% | $9.09M+6.8% | $9.77M+11.6% | $10.39M+17.4% | ||
| -$96.57M-52.9% | -$71.91M-17.7% | -$67.83M-39.1% | -$57.39M-36.1% | -$63.16M-59.1% | ||
| $1.94M-27.6% | $1.05M-70.0% | $5.13M+144% | $2.71M+15.5% | $2.68M+38.1% | ||
| —— | -$123.83M-585% | $346K+100% | $50.48M+337% | $71.5M+155% | ||
| $66K+1,000% | $19.98M+1,256% | $236.01M+17.7% | $1.16M-97.5% | $6K-100.0% | ||
| -$3.51M-142% | -$175.77M-416% | $168.52M+1,439% | -$5.76M— | $8.34M-87.5% | ||
| -$98.51M-49.6% | -$72.96M-13.0% | -$72.96M-43.5% | -$60.1M-35.0% | -$65.84M-58.1% |
FAQ
- How much cash does Nurix Therapeutics, Inc. generate?
- Nurix Therapeutics, Inc. (NRIX) generated -$293.7M in operating cash flow over the trailing twelve months.
- What is Nurix Therapeutics, Inc.'s free cash flow?
- After $10.8M of capital expenditures, Nurix Therapeutics, Inc.'s free cash flow was -$304.5M over the trailing twelve months, down 34.9% year over year.
- Where does Nurix Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Nurix Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
